Reply to “A Word of Caution in Considering the Use of the Lipoarabinomannan Lateral Flow Assay on Cerebrospinal Fluid for Detection of Tuberculous Meningitis” | Zendy

Janneke Cox | Zendy; Robert Colebunders | Zendy; Yukari C. Manabe | Zendy

Open Access

Reply to “A Word of Caution in Considering the Use of the Lipoarabinomannan Lateral Flow Assay on Cerebrospinal Fluid for Detection of Tuberculous Meningitis”

Author(s) -

Janneke Cox,

Robert Colebunders,

Yukari C. Manabe

Publication year - 2015

Publication title -

journal of clinical microbiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.349

H-Index - 255

eISSN - 1070-633X

pISSN - 0095-1137

DOI - 10.1128/jcm.02823-15

Subject(s) - lipoarabinomannan , cerebrospinal fluid , tuberculous meningitis , meningitis , medicine , pathology , tuberculosis , mycobacterium tuberculosis , surgery

In their [letter][1], Bahr and colleagues report their inability to detect lipoarabinomannan (LAM) in the cerebrospinal fluid (CSF) of patients with tuberculous meningitis (TBM) by using a lateral flow assay (Determine TB LAM; Alere, Waltham, MA, USA). Several studies have shown LAM positivity in

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research